Risk factors for acute respiratory distress syndrome during neutropenia recovery in patients with hematologic malignancies

被引:39
作者
Rhee, Chin Kook [1 ]
Kang, Ji Young [1 ]
Kim, Yong Hyun [1 ]
Kim, Jin Woo [1 ]
Yoon, Hyung Kyu [1 ]
Kim, Seok Chan [1 ]
Kwon, Soon Suk [1 ]
Kim, Young Kyoon [1 ]
Kim, Kwan Hyung [1 ]
Moon, Hwa Sik [1 ]
Park, Sung Hak [1 ]
Kim, Hee Je [2 ]
Lee, Seok [2 ]
Song, Jeong Sup [1 ]
机构
[1] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Pulm & Crit Care Med, Seoul 137701, South Korea
[2] Catholic Univ Korea, Coll Med, Dept Internal Med, Catholic Hematopoiet Stem Cell Transplantat Ctr, Seoul 137701, South Korea
来源
CRITICAL CARE | 2009年 / 13卷 / 06期
关键词
COLONY-STIMULATING FACTOR; ACUTE LUNG INJURY; 3-WEEKLY CHOP CHEMOTHERAPY; INTENSIVE-CARE-UNIT; CANCER-PATIENTS; BONE-MARROW; G-CSF; AGGRESSIVE LYMPHOMAS; PULMONARY TOXICITY; DETERIORATION;
D O I
10.1186/cc8149
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Introduction Neutropenia recovery may be associated with deterioration in oxygenation and exacerbation of pre-existing pulmonary disease. However, risk factors for acute respiratory distress syndrome (ARDS) during neutropenia recovery in patients with hematologic malignancies have not been studied. Methods We studied critically ill patients with hematologic malignancies with the dual objectives of describing patients with ARDS during neutropenia recovery and identifying risk factors for ARDS during neutropenia recovery. A cohort of consecutive neutropenic patients with hematologic malignancies who were admitted to the intensive care unit (ICU) was studied. During a 6-year period, 71 patients recovered from neutropenia, of whom 38 (53.5%) developed ARDS during recovery. Results Compared with non-ARDS patients, patients who experienced ARDS during neutropenia recovery were more likely to have pneumonia, be admitted to the ICU for respiratory failure, and receive mechanical ventilator therapy. The in-ICU mortality was significantly different between the two groups (86.8% versus 51.5%, respectively, for patients who developed ARDS during neutropenia recovery versus those who did not during neutropenia recovery). In multivariate analysis, only occurrence of pneumonia during the neutropenic episode was associated with a marked increase in the risk of ARDS (odds ratio, 4.76). Conclusions Patients with hematologic malignancies complicated by pneumonia during neutropenia are at increased risk for ARDS during neutropenia recovery.
引用
收藏
页数:8
相关论文
共 39 条
[1]   G-CSF and IL-8 but not GM-CSF correlate with severity of pulmonary neutrophilia in acute respiratory distress syndrome [J].
Aggarwal, A ;
Baker, CS ;
Evans, TW ;
Haslam, PL .
EUROPEAN RESPIRATORY JOURNAL, 2000, 15 (05) :895-901
[2]   USE OF BRONCHOALVEOLAR LAVAGE IN THE EVALUATION OF METHOTREXATE LUNG-DISEASE [J].
AKOUN, GM ;
MAYAUD, CM ;
TOUBOUL, JL ;
DENIS, MF ;
MILLERON, BJ ;
PERROT, JY .
THORAX, 1987, 42 (09) :652-655
[3]   Exacerbation with granulocyte colony-stimulating factor of prior acute lung injury during neutropenia recovery in rats [J].
Azoulay, É ;
Attalah, H ;
Yang, K ;
Herigault, S ;
Jouault, H ;
Brun-Buisson, C ;
Brochard, L ;
Harf, A ;
Schlemmer, B ;
Delclaux, C .
CRITICAL CARE MEDICINE, 2003, 31 (01) :157-165
[4]   Deterioration of previous acute lung injury during neutropenia recovery [J].
Azoulay, E ;
Darmon, M ;
Delclaux, C ;
Fieux, F ;
Bornstain, C ;
Moreau, D ;
Attalah, H ;
Le Gall, JR ;
Schlemmer, B .
CRITICAL CARE MEDICINE, 2002, 30 (04) :781-786
[5]   Granulocyte colony-stimulating factor or neutrophil-induced pulmonary toxicity: Myth or reality? Systematic review of clinical case reports and experimental data [J].
Azoulay, E ;
Attalah, H ;
Harf, A ;
Schlemmer, B ;
Delclaux, C .
CHEST, 2001, 120 (05) :1695-1701
[6]   Changing use of intensive care for hematological patients: the example of multiple myeloma [J].
Azoulay, E ;
Recher, C ;
Alberti, C ;
Soufir, L ;
Leleu, G ;
Le Gall, JR ;
Fermand, JP ;
Schlemmer, B .
INTENSIVE CARE MEDICINE, 1999, 25 (12) :1395-1401
[7]   Outcome and early prognostic indicators in patients with a hematologic malignancy admitted to the intensive care unit for a life-threatening complication [J].
Benoit, DD ;
Vandewoude, KH ;
Decruyenaere, JM ;
Hoste, EA ;
Colardyn, FA .
CRITICAL CARE MEDICINE, 2003, 31 (01) :104-112
[8]   Pulmonary toxicity of induction chemotherapy prior to standard or high-dose chemotherapy with autologous hematopoietic support [J].
Bhalla, KS ;
Wilczynski, SW ;
Abushamaa, AM ;
Petros, WP ;
McDonald, CS ;
Loftis, JS ;
Chao, NJ ;
Vredenburgh, JJ ;
Folz, RJ .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 161 (01) :17-25
[9]   MECHANICAL VENTILATION AFTER MARROW TRANSPLANTATION - RISK-FACTORS AND CLINICAL OUTCOME [J].
CRAWFORD, SW ;
SCHWARTZ, DA ;
PETERSEN, FB ;
CLARK, JG .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1988, 137 (03) :682-687
[10]  
DeMagalhaesSilverman M, 1996, BONE MARROW TRANSPL, V17, P329